515 related articles for article (PubMed ID: 32652044)
1. The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study.
Wu H; Tremaroli V; Schmidt C; Lundqvist A; Olsson LM; Krämer M; Gummesson A; Perkins R; Bergström G; Bäckhed F
Cell Metab; 2020 Sep; 32(3):379-390.e3. PubMed ID: 32652044
[TBL] [Abstract][Full Text] [Related]
2. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
3. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
4. Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis.
Liao X; Song L; Zeng B; Liu B; Qiu Y; Qu H; Zheng Y; Long M; Zhou H; Wang Y; Du Y; Xu J; Shen R; Tong Q; Cai L; Li X; Guo S; Yang G; Zhu Z; Pu X; Wei H; Zheng H
EBioMedicine; 2019 Jun; 44():665-674. PubMed ID: 30922964
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes.
Li J; Morrow C; Barnes S; Wilson L; Womack ED; McLain A; Yarar-Fisher C
Arch Phys Med Rehabil; 2022 Apr; 103(4):702-710. PubMed ID: 34126067
[TBL] [Abstract][Full Text] [Related]
6. Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark.
Pinna NK; Anjana RM; Saxena S; Dutta A; Gnanaprakash V; Rameshkumar G; Aswath S; Raghavan S; Rani CSS; Radha V; Balasubramanyam M; Pant A; Nielsen T; Jørgensen T; Færch K; Kashani A; Silva MCA; Vestergaard H; Hansen TH; Hansen T; Arumugam M; Nair GB; Das B; Pedersen O; Mohan V; Mande SS
Genome Med; 2021 Mar; 13(1):36. PubMed ID: 33658065
[TBL] [Abstract][Full Text] [Related]
7. Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study.
Gravdal K; Kirste KH; Grzelak K; Kirubakaran GT; Leissner P; Saliou A; Casèn C
BMC Endocr Disord; 2023 Aug; 23(1):179. PubMed ID: 37605183
[TBL] [Abstract][Full Text] [Related]
8. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
9. Peanut skin extract ameliorates the symptoms of type 2 diabetes mellitus in mice by alleviating inflammation and maintaining gut microbiota homeostasis.
Xiang L; Wu Q; Osada H; Yoshida M; Pan W; Qi J
Aging (Albany NY); 2020 Jul; 12(14):13991-14018. PubMed ID: 32699185
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies.
Letchumanan G; Abdullah N; Marlini M; Baharom N; Lawley B; Omar MR; Mohideen FBS; Addnan FH; Nur Fariha MM; Ismail Z; Pathmanathan SG
Front Cell Infect Microbiol; 2022; 12():943427. PubMed ID: 36046745
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients.
Díaz-Perdigones CM; Muñoz-Garach A; Álvarez-Bermúdez MD; Moreno-Indias I; Tinahones FJ
Biomed Pharmacother; 2022 Jan; 145():112448. PubMed ID: 34844104
[TBL] [Abstract][Full Text] [Related]
12. Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes.
Estrella MY; Daniel NR; Armando ED; Cristian PM; Aarón VJ; Paul SJ; David GV; Cristian MO; de Lourdes RM; Lola EM; Alberto AG; Osbaldo RA; Rodolfo GM
Sci Rep; 2024 Apr; 14(1):9678. PubMed ID: 38678119
[TBL] [Abstract][Full Text] [Related]
13. Considering gut microbiota in treatment of type 2 diabetes mellitus.
Adeshirlarijaney A; Gewirtz AT
Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
[TBL] [Abstract][Full Text] [Related]
14. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
15. Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes.
van Bommel EJM; Herrema H; Davids M; Kramer MHH; Nieuwdorp M; van Raalte DH
Diabetes Metab; 2020 Apr; 46(2):164-168. PubMed ID: 31816432
[TBL] [Abstract][Full Text] [Related]
16. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
17. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.
Cao TTB; Wu KC; Hsu JL; Chang CS; Chou C; Lin CY; Liao YM; Lin PC; Yang LY; Lin HW
Front Endocrinol (Lausanne); 2020; 11():573891. PubMed ID: 33071980
[No Abstract] [Full Text] [Related]
18. Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes.
Arora T; Tremaroli V
Front Endocrinol (Lausanne); 2021; 12():761834. PubMed ID: 34737725
[TBL] [Abstract][Full Text] [Related]
19. Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats.
Zhang Q; Xiao X; Li M; Yu M; Ping F; Zheng J; Wang T; Wang X
PLoS One; 2017; 12(10):e0184735. PubMed ID: 29036231
[TBL] [Abstract][Full Text] [Related]
20. Oleuropein Ameliorates Advanced Stage of Type 2 Diabetes in
Zheng S; Wang Y; Fang J; Geng R; Li M; Zhao Y; Kang SG; Huang K; Tong T
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
